Rational Use of Danofloxacin for Treatment of Mycoplasma gallisepticum in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift

The study was to explore the rational use of danofloxacin against Mycoplasma gallisepticum (MG) based on its clinical breakpoint (CBP) and the effect on lung microbiota. The CBP was established according to epidemiological cutoff value (ECV/CO(WT)), pharmacokinetic–pharmacodynamic (PK–PD) cutoff val...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuge, Huang, Anxiong, Gu, Yufeng, Li, Jun, Huang, Lingli, Wang, Xu, Tao, Yanfei, Liu, Zhenli, Wu, Congming, Yuan, Zonghui, Hao, Haihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944443/
https://www.ncbi.nlm.nih.gov/pubmed/35326865
http://dx.doi.org/10.3390/antibiotics11030403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944443/
https://www.ncbi.nlm.nih.gov/pubmed/35326865
http://dx.doi.org/10.3390/antibiotics11030403

Ejemplares similares